NCT01143350

Brief Summary

The STIM-EHPAD study (for stimulation in nursing home) aims to evaluate the short and medium term effectiveness of staff education as a non-pharmacological intervention to manage apathy in older people with a diagnosis of dementia.

  • Primary efficacy criteria: Apathy Inventory clinician score changes
  • Secondary efficacy criteria: Apathy Inventory patient and caregiver version changes, Observation scale changes, frequency and severity of the other BPSD using the NPI, qualitative analysis of the nursing home staff behavioural changes

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2010

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 14, 2010

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

June 1, 2011

Status Verified

March 1, 2010

Enrollment Period

Same day

First QC Date

February 25, 2010

Last Update Submit

May 31, 2011

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identification of yet unknown enzymes involved in the processing of Ab, especially on those responsible for the exoproteasic truncation of Ab at its N-terminus.

    Identification of yet unknown enzymes involved in the processing of Ab, especially on those responsible for the exoproteasic truncation of Ab at its N-terminus.

    1 year

Secondary Outcomes (1)

  • Secondary efficacy criteria: Apathy Inventory patient and caregiver version changes, Observation scale changes, frequency and severity of the other BPSD using the NPI, qualitative analysis of the nursing home staff behavioural changes

    1 year

Study Arms (2)

EHPAD Training and Stimulation

EXPERIMENTAL

EHPAD of the group of Training / Stimulation will benefit: * after a training in behaviours to be held or in methods of stimulation aiming at the reduction of disturbances of behaviour at type of apathy. This information will be transmitted in l 'ensemble of l 'équipe of l 'EHPAD by a training officer. * of a structuring of the activities of animation offered to the inhabitants, This information will be regrouped in chips worked out like TNM - EHPAD.

Other: Bras A (EHPAD Training and stimulation)

2- EHPAD control

PLACEBO COMPARATOR

EHPAD of the reference group, will have their habitual functioning

Other: EHPAD Control

Interventions

EHPAD of the group of Training / Stimulation will benefit: * after a training in behaviours to be held or in methods of stimulation aiming at the reduction of disturbances of behaviour at type of apathy. This information will be transmitted in l 'ensemble of l 'équipe of l 'EHPAD by a training officer. * of a structuring of the activities of animation offered to the inhabitants, This information will be regrouped in chips worked out like TNM - EHPAD.

EHPAD Training and Stimulation

EHPAD of the reference group, will have their habitual functioning

2- EHPAD control

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients older than 65 years
  • A diagnosis of dementia according to the ICD 10 criteria
  • MMSE score ≤ 24
  • Presenting the diagnostic criteria of apathy (cf page ??)
  • An Apathy Inventory clinician total score \>3 (with at least a score higher than 1 at one of the 3 dimensions; lack of initiative, lack of interest, emotional blunting)

You may not qualify if:

  • Patients more than 65 years
  • MMSE score \> 24

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Robert

Nice, Alpes-Maritimes, 06001, France

Location

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Philippe Ph ROBERT, PhD

    CHU de Nice - CM2R - Hôpital de Cimiez - 4 avenue reine victoria - 06 003 Nice cedex 1

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 25, 2010

First Posted

June 14, 2010

Study Start

March 1, 2010

Primary Completion

March 1, 2010

Study Completion

March 1, 2011

Last Updated

June 1, 2011

Record last verified: 2010-03

Locations